Evidence map›Paper›PMID 20593373›Full record

ArticleMagnetic resonance in medicine2010

Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging.

Karen C Briley-Saebo, Marylene Leboeuf, Stephen Dickson, Venkatesh Mani, Zahi A Fayad, A Karolina Palucka, Jacques Banchereau, Miriam Merad

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karen C Briley-SaeboDepartment of Radiology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA. karen.saebo@mountsinai.org
Marylene Leboeuf
Stephen Dickson
Venkatesh Mani
Zahi A Fayad
A Karolina Palucka
Jacques Banchereau
Miriam Merad

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI LEGRAND, ROGER · 2003 to 2013
$49.2M
Neutrophils in Lupus PathogenesisP50AR054083 · NIAMS · BAYLOR RESEARCH INSTITUTE · PI PASCUAL, MARIA VIRGINIA · 2006 to 2010
$6.2M
SUBPOPULATIONS OF HUMAN DENDRITIC CELLSR01CA078846 · NCI · BAYLOR RESEARCH INSTITUTE · PI BANCHEREAU, JACQUES F · 1999 to 2008
$2.5M
NCI NIH HHS R01 CA078846NCI NIH HHS R01-CA078846NIAID NIH HHS U19 AI057234NIAMS NIH HHS AR054083-01NIAMS NIH HHS P50 AR054083PHS HHS U19-A1057234
6 · The paper itself

Abstract

Ex vivo generated dendritic cells are currently used to induce therapeutic immunity in solid tumors. Effective immune response requires dendritic cells to home and remain in lymphoid organs to allow for adequate interaction with T lymphocytes. The aim of the current study was to detect and track Feridex labeled human dendritic cells in murine models using magnetic resonance imaging. Human dendritic cells were incubated with Feridex and the effect of labeling on dendritic cells immune function was evaluated. Ex vivo dendritic cell phantoms were used to estimate sensitivity of the magnetic resonance methods and in vivo homing was evaluated after intravenous or subcutaneous injection. R2*-maps of liver, spleen, and draining lymph nodes were obtained and inductively coupled plasma mass spectrometry or relaxometry methods were used to quantify the Feridex tissue concentrations. Correlations between in vivo R2* values and iron content were then determined. Feridex labeling did not affect dendritic cell maturation or function. Phantom results indicated that it was possible to detect 125 dendritic cells within a given slice. Strong correlation between in vivo R2* values and iron deposition was observed. Importantly, Feridex-labeled dendritic cells were detected in the spleen for up to 2 weeks postintravenous injection. This study suggests that magnetic resonance imaging may be used to longitudinally track Feridex-labeled human dendritic cells for up to 2 weeks after injection.

Indexed as

AnimalsCells, CulturedCell TrackingDendritic CellsHumansMagnetic Resonance ImagingMiceMice, Inbred C57BLMice, Knockout

Identifiers

PMID20593373
PMCPMC3068597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.